Bank of New York Mellon Corp - FINCH THERAPEUTICS GROUP INC ownership

Back to all holdings Add to watchlist

FINCH THERAPEUTICS GROUP INC's ticker is FNCH and the CUSIP is 31773D101. A total of 46 filers reported holding FINCH THERAPEUTICS GROUP INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.2%.

Links
Filings
External links
Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of FINCH THERAPEUTICS GROUP INC
ValueSharesWeighting
Q1 2022$126,000
-50.6%
25,037
-2.2%
0.00%–
Q4 2021$255,000
-22.3%
25,602
+1.6%
0.00%–
Q3 2021$328,000
+52.6%
25,206
+64.5%
0.00%–
Q2 2021$215,000–15,325–0.00%–
 Download
Other shareholders
FINCH THERAPEUTICS GROUP INC shareholders Q3 2021
NameSharesValueWeighting ↓
Avenir Management Company, LLC 1,663,366$653,7033.23%
Bleichroeder LP 810,416$318,4930.07%
Ikarian Capital, LLC 237,553$93,3590.02%
LAKE STREET ADVISORS GROUP, LLC 739,136$2910.02%
Baupost Group 2,019,008$7930.01%
Proficio Capital Partners LLC 110,559$43,4500.01%
MSD Partners, L.P. 153,397$60,2850.01%
Ballentine Partners, LLC 143,603$56,4360.00%
SVB WEALTH LLC 253,054$99,4500.00%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 18,783$7,3820.00%
View complete list of FINCH THERAPEUTICS GROUP INC shareholders